FDA proposes long-awaited patient medication information rule

Regulatory NewsRegulatory NewsAdvertising, Promotion and LabelingBiologics/ biosimilars/ vaccinesComplianceEthicsNorth AmericaOtherPharmaceuticalsRegulatory Intelligence/Policy